Table 1 The descriptive data of eligible studies. The unit of ST-elevation size is millimeter
Author and publish year | Duration of study (year) | Country | Type of study | Number of patients and grouping | Total mean age ± SD | Male/female | Score of quality assessment |
|---|---|---|---|---|---|---|---|
Ashraf. H et al. (2011) [29] | 1 | Egypt | Cross-sectional | 81 ST-elevation AVR ≥ 0.5 mm 69 non-ST-elevation AVR | 59 ± 9 | 115/35 | 16 |
Rathi. N et al. (2016) [41] | 1 | Pakistan | Cross-sectional | 81 ST-elevation AVR ≥ 0.5 mm 33 non-ST-elevation AVR | 56.65 ± 15.44 | 88/26 | 14 |
Katırcıbaşı. T. M et al. (2007) [30] | 6 | Turkey | Cross-sectional | 65 ST-elevation AVR ≥ 1 mm 39 non-ST-elevation AVR | 60.6 | 79/25 | 14 |
Kosuge. M et al. (2008) [33] | 1 | Japan | Cross-sectional | 92 ST-elevation AVR ≥ 0.5 mm 275 non-ST-elevation AVR | 67 ± 10 | 252/115 | 15 |
Rostoff. P et al. (2006) [42] | Unclear | Poland | Cross-sectional | 54 ST-elevation AVR ≥ 0.5 mm 80 non-ST-elevation AVR | 59.9 ± 9.7 | 92/42 | 12 |
Nabati. M et al. (2017) [38] | 1 | Iran | Cohort | 52 ST-elevation AVR ≥ 0.5 mm 77 non-ST-elevation AVR | 58.40 ± 10.64 | 65/64 | 13 |
Y. M. Marrero (2020) [37] | 3 | Cuba | Cross-sectional | 34st-elevation AVR ≥ 0.5 mm 78 non-ST-elevation AVR | 62.5 ± 12.4 | 68/44 | 13 |
Kosuge. M et al. (2009) [32] | Unclear | Japan | Cross-sectional | 345 ST-elevation AVR ≥ 0.5 mm 156 non-ST-elevation AVR | 66 ± 11 | 348/153 | 14 |
Kosuge. M et al. (2005) [35] | 4 | Japan | Cross-sectional | 83 ST-elevation AVR ≥ 0.5 mm 227 non-ST-elevation AVR | 66 ± 10 | 213/97 | 13 |
Kosuge. M et al. (2006) [34] | 4 | Japan | Cross-sectional | 90 ST-elevation AVR ≥ 0.5 mm 243 non-ST-elevation AVR | 67 ± 10 | 230/103 | 16 |
Kosuge. M et al. (2011) [31] | Unclear | Japan | Cross-sectional | 157 ST-elevation AVR ≥ 0.5 mm 415 non-ST-elevation AVR | 67 ± 11 | 397/115 | 15 |
Kosuge. M et al. (2001) [36] | 5 | Japan | Cross-sectional | 23 ST-elevation AVR ≥ 0.5 mm 82 non-ST-elevation AVR | 58 | 91/14 | 13 |
Ozmen.N et al. (2010)* [40] | Unclear | Turkey | Case–control | 21 ST-elevation AVR ≥ 0.5 mm 40 non-ST-elevation AVR | 47.86 | 42/19 | 19 |
Nough. H et al. (2012) [39] | 1 | Iran | Cross-sectional | 81 0.05 ≤ ST-elevation AVR < 1 mm 43 ST-elevation AVR ≥ 1 mm 276 non-ST-elevation AVR | 61.0 ± 12 | 257/143 | 13 |
N. Misumida et al. (2016) [5] | 1 | Israel | Cross-sectional | 97 ST-elevation AVR ≥ 0.5 mm 282 non-ST-elevation AVR | 64.7 | 226/153 | 15 |
Rostoff. P et al. (2005) [43] | Unclear | Poland | Cross-sectional | 54 ST-elevation AVR ≥ 0.5 mm 80 non-ST-elevation AVR | 60.6 ± 9.5 | 92/42 | 12 |
Ruiz-Mateos. B et al. (2020) [44] | Unclear | Spain | Cohort | 20 ST-elevation AVR 322 non-ST-elevation AVR | 60 | 275/67 | 11 |
Separham. A et al. (2018) [45] | 1 | Iran | Cohort | 122 ST-elevation AVR ≥ 0.5 mm 278 non-ST-elevation AVR | 63.93 ± 13.05 | 285/115 | 14 |
Jalal. U. M et al. (2019) [47] | 1 | Bangladesh | Cross-sectional | 6 ST-elevation AVR ≥ 0.5 mm 101 non-ST-elevation AVR | 56.36 | 95/12 | 10 |
Wong. C et al. (2010) [48] | Unclear | New Zealand | Cohort | 1685 ST-elevation AVR = 0.5 mm 819 ST-elevation AVR = 1 mm 325 ST-elevation AVR ≥ 1.5 mm 12,996 non-ST-elevation AVR | 60.77 | 11,375/4450 | 15 |
Tang, et al. (2008) [46] | 4.5 | China | Cross-sectional | 26 ST-elevation AVR ≥ 0.5 mm 30 non-ST-elevation AVR | 65.92 | 33/17 | 14 |
Wong. C et al. (2012) [49] | Unclear | New Zealand | Cohort | 1109 ST-elevation AVR ≥ 1 mm 14,206 non-ST-elevation AVR | 60.77 | Total = 15,315 | 13 |
Wu et al. (2008) [50] | Unclear | China | Cross-sectional | 68 0.05 ≤ ST-elevation AVR < 1 mm 77 ST-elevation AVR ≥ 1 mm 281 non-ST-elevation AVR | 58.92 | 292/134 | 14 |
Yamaji. H et al. (2002) [51] | Unclear | Japan | Cross-sectional | 36 ST-elevation AVR ≥ 0.5 mm 12 non-ST-elevation AVR | – | Total = 48 | 13 |
Yan. T.A et al. (2007) [52] | 5 | 13 countries | Cross-sectional | 292 0.05 ≤ ST-elevation AVR < 1 mm 76 ST-elevation AVR ≥ 1 mm 4696 non-ST-elevation AVR | 66.23 | 3199/1865 | 14 |
Zhang. X et al. (2015) [54] | 4 | China | Cross-sectional | 192 ST-elevation AVR ≥ 0.5 mm 254 non-ST-elevation AVR | 62.1 ± 12 | 335/91 | 14 |
Yan. Y et al. (2015) [53] | 3 | China | Cross-sectional | 54 ST-elevation AVR ≥ 0.5 mm 141 non-ST-elevation AVR | 62.96 | 112/83 | 13 |
Gaffari. S et al. (2016) [24] | 1 | Iran | Cohort | 64 ST-elevation AVR < 1 mm 106 1 ≤ ST-elevation AVR < 2 mm 60 ST-elevation AVR ≥ 2 mm | 55.96 ± 8.91 | 159/71 | 13 |
Alherbish. A et al. (2013) [12] | 2 | Canada, New Zealand, NC | Cohort | 3819 non-ST-elevation AVR 352 ST-elevation AVR ≥ 1 mm | 60.79 | 4289/1349 | 16 |
Cerit. L et al. (2017) [19] | 3 | Cyprus | Cross-sectional | 37 non-ST-elevation AVR 80 ST-elevation AVR ≥ 0.5 mm | 61.35 | 89/28 | 15 |
Barrabés. J et al. (2003) [17] | 15 | Spain | Cross-sectional | 525 non-ST-elevation AVR 116 0.5 ≤ ST-elevation AVR < 1 mm 134 ST-elevation AVR ≥ 1 mm | 61.3 | 592/183 | 14 |
Gachchhadar. P et al. (2018) [23] | 1 | Bangladesh | Cross-sectional | 11 ST-elevation AVR < 0.75 mm 25 ST-elevation AVR > 0.75 mm | 56.4 | 30/6 | 14 |
Goto. Y et al. (2011) [25] | 6 | Japan | Cross-sectional | 106 non-ST-elevation AVR 85 ST-elevation AVR ≥ 0.5 mm | 62 ± 10 | 185/52 | 14 |
Hengrussamee A et al. (2005) [26] | 1 | Thailand | Cross-sectional | 17 non-ST-elevation AVR 9 ST-elevation AVR ≥ 0.5 mm | 64 ± 9 | 21/5 | 11 |
Baheti. A et al. (2021) [16] | 2 | America | Cohort | 567 non-ST-elevation AVR 74 ST-elevation AVR ≥ 1 mm | 57 | 366/275 | 15 |
Ducas. R et al. (2013) [22] | 4 | Canada | Cohort | 138 non-ST-elevation AVR 53 ST-elevation AVR ≥ 0.5 mm | 68 | 132/59 | 14 |
Hirano. T et al. (2006) [27] | 16 | Japan | Cross-sectional | 101 non-ST-elevation AVR 39 ST-elevation AVR ≥ 0.5 mm | 65 | 96/44 | 13 |
Chen. Y et al. (2004) [21] | 15 | Taiwan | Cross-sectional | 6 non-ST-elevation AVR 16 ST-elevation AVR > 0.5 mm | 63.68 | 18/4 | 12 |
Badri. M et al. (2019) [15] | 2 | Egypt | Cross-sectional | 21 non-ST-elevation AVR 39 ST-elevation AVR ≥ 0.5 mm | 60 ± 9 | 37/28 | 15 |
Aygül. N et al. (2006) [13] | 4 | Turkey | Cross-sectional | 315 non-ST-elevation AVR 46 ST-elevation AVR ≥ 0.5 mm | 58 ± 10 | 293/68 | 13 |
Aygul. N et al. (2008) [14] | 6 | Turkey | Cross-sectional | 795 non-ST-elevation AVR 155 ST-elevation AVR > 0.5 mm | 59 ± 12 | 742/208 | 14 |
Sheibani. H et al. (2021) [28] | 1 | Iran | Cross-sectional | 335 non-ST-elevation AVR 137 ST-elevation AVR ≥ 0.5 mm | 61 ± 14 | 248/224 | 12 |
Beyranvand. M et al. (2017) [18] | 3 | Iran | Cross-sectional | 116 non-ST-elevation AVR 79 0.5 ≤ ST-elevation AVR < 1 mm 24 ST-elevation AVR ≥ 1 mm | 59.00 ± 13.14 | 228/60 | 12 |
Chen. Y et al. (2005) [20] | 7 | Taiwan | Cross-sectional | 38 non-ST-elevation AVR 18 0.5 ≤ ST-elevation AVR < 1 mm 22 ST-elevation AVR ≥ 1 mm | 63.68 | 18/4 | 10 |
Abbase. A et al. (2011) [11] | 1 | Iraq | Cross-sectional | 56 None 43 ST-elevation AVR ≥ 0.5 | 56.44 | 65/35 | 12 |